Reperfusion and outcomes in Penumbra vs. systemic tissue plasminogen activator clinical trials.
Alexandrov AV, Schellinger PD, Saqqur M, Barreto A, Demchuk AM, Ribo M, Rubiera M, Sharma VK, Heliopoulos I, Alexandrov AW, Molina CA, Tsivgoulis G; CLOTBUST and TUCSON Investigators.
Alexandrov AV, et al. Among authors: alexandrov aw.
Int J Stroke. 2011 Apr;6(2):118-22. doi: 10.1111/j.1747-4949.2010.00559.x. Epub 2010 Dec 23.
Int J Stroke. 2011.
PMID: 21371272